Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
2.530
+0.040 (1.61%)
Apr 17, 2026, 9:44 AM EDT - Market open
Acurx Pharmaceuticals Market Cap
Acurx Pharmaceuticals has a market cap or net worth of $7.22 million as of April 17, 2026. Its market cap has decreased by -15.98% in one year.
Market Cap
7.22M
Enterprise Value
-447.09K
1-Year Change
-15.98%
Ranking
Category
Stock Price
$2.53
Market Cap Chart
Since the IPO on June 25, 2021, Acurx Pharmaceuticals's market cap has decreased from $57.25M to $7.22M, a decrease of -87.38%. That is a compound annual growth rate of -34.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 8.85M | 51.37% |
| Dec 31, 2025 | 5.85M | -57.48% |
| Dec 31, 2024 | 13.75M | -73.92% |
| Dec 29, 2023 | 52.73M | 14.29% |
| Dec 30, 2022 | 46.14M | 4.51% |
| Dec 31, 2021 | 44.15M | -22.88% |
| Jun 25, 2021 | 57.25M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CalciMedica | 10.00M |
| Traws Pharma | 9.83M |
| Bolt Biotherapeutics | 9.43M |
| NuCana | 9.07M |
| Creative Medical Technology Holdings | 8.58M |
| Liminatus Pharma | 8.33M |
| PharmaCyte Biotech | 8.18M |
| TransCode Therapeutics | 8.17M |